Ausgabe 2/2000
Inhalt (14 Artikel)
Strategies to Optimize CAD Prevention in Modern Cardiology The “Marburg CAD Prevention Project”
Juergen R. Schaefer, Bernd Simon, Muhidien Soufi, Alexander Sattler, Bernd Noll, Matthias Herzum, Bernhard Maisch
Inflammation and Acute Coronary Syndromes
Luigi M. Biasucci, Giovanna Liuzzo, Dominik J. Angiolillo, Giovanni Sperti, Attilio Maseri
HMG-CoA Reductase Inhibition: Anti-Inflammatory Effects beyond Lipid Lowering?
Winfried März, Heinrich Wieland
The VEGF Splice Variants: Properties, Receptors, and Usage for the Treatment of Ischemic Diseases
Zoya Poltorak, Tzafra Cohen, Gera Neufeld
Potassium Channel Openers and Blockers in Coronary Artery Disease Comparison to Betablockers and Calcium Antagonists
Veselin Mitrovic, Eckart Oehm, Jochen Thormann, Heinz Pitschner, Christian Hamm
Atherogenetically Relevant Cells Support Continuous Growth of Chlamydia Pneumoniae
Matthias Maass, Jens Gieffers, Werner Solbach
Immune Responses to Chlamydia Antigens in Atherosclerosis
John S.H. Gaston, Allison J. Curry, Irene Portig, Jane C. Goodall, Peter J. Kirkpatrick
Chlamydia Pneumoniae Infection is Not an Independent Risk Factor for Arterial Disease
Werner Haberbosch, Christian Jantos
Restenosis after Percutaneous Coronary Interventions and Infection
Matthias Herzum, Juergen R. Schaefer, Bernd Simon, Volker Menz, Bernd Noll, Bernhard Maisch
Transplant Vasculopathy: a Model for Coronary Artery Disease?
Mario C. Deng, Gabriele Plenz, Michael Erren, Markus J. Wilhelm, Gerold Moennig, Markus Rothenburger, Hider A. Baba